Dimebon as a potential therapy for Alzheimer's disease.
Excellent treatment for Alzheimer's disease remains an unmet medical need. Although current therapies improve patients' abilities compared to placebo and temporarily maintain performance above baseline on a number of outcome measures, additional therapies are needed to augment the benefits over baseline and to prolong these improvements.
Doody
Rachelle S
RS
Alzheimer's Disease Research, Baylor College of Medicine, Houston, Texas, USA.
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000503:physiopathology; D006633:Histamine Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007211:Indoles / Q000494:pharmacology* / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
D006633:Histamine Antagonists; D007211:Indoles; C010119:latrepirdine